Cargando…
Editorial: From Chronic Inflammation to Cancer: How Far Can Immunotherapy Go?
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820386/ https://www.ncbi.nlm.nih.gov/pubmed/35140611 http://dx.doi.org/10.3389/fphar.2021.838917 |
_version_ | 1784646214457753600 |
---|---|
author | Li, Xuefeng Teng, Lesheng Yang, Zhaogang |
author_facet | Li, Xuefeng Teng, Lesheng Yang, Zhaogang |
author_sort | Li, Xuefeng |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8820386 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88203862022-02-08 Editorial: From Chronic Inflammation to Cancer: How Far Can Immunotherapy Go? Li, Xuefeng Teng, Lesheng Yang, Zhaogang Front Pharmacol Pharmacology Frontiers Media S.A. 2022-01-12 /pmc/articles/PMC8820386/ /pubmed/35140611 http://dx.doi.org/10.3389/fphar.2021.838917 Text en Copyright © 2022 Li, Teng and Yang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Li, Xuefeng Teng, Lesheng Yang, Zhaogang Editorial: From Chronic Inflammation to Cancer: How Far Can Immunotherapy Go? |
title | Editorial: From Chronic Inflammation to Cancer: How Far Can Immunotherapy Go? |
title_full | Editorial: From Chronic Inflammation to Cancer: How Far Can Immunotherapy Go? |
title_fullStr | Editorial: From Chronic Inflammation to Cancer: How Far Can Immunotherapy Go? |
title_full_unstemmed | Editorial: From Chronic Inflammation to Cancer: How Far Can Immunotherapy Go? |
title_short | Editorial: From Chronic Inflammation to Cancer: How Far Can Immunotherapy Go? |
title_sort | editorial: from chronic inflammation to cancer: how far can immunotherapy go? |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820386/ https://www.ncbi.nlm.nih.gov/pubmed/35140611 http://dx.doi.org/10.3389/fphar.2021.838917 |
work_keys_str_mv | AT lixuefeng editorialfromchronicinflammationtocancerhowfarcanimmunotherapygo AT tenglesheng editorialfromchronicinflammationtocancerhowfarcanimmunotherapygo AT yangzhaogang editorialfromchronicinflammationtocancerhowfarcanimmunotherapygo |